Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Jeffrey Eberwein, Lone Star Increase Stake in Crossroads Systems

Jeffrey Eberwein’s Lone Star Value Management disclosed that it has slightly increased its position in Crossroads Systems, Inc. (NASDAQ:CRDS) to 805,263 shares, equal to 6.7% of the company’s common stock. The position has been upped from 670,000 shares reported by Lone Star at the beginning of November, when the fund initiated an activist stake in the company.  The position involves 790,600 shares of common stock, plus around 14,700 shares in form of options to purchase common stock held by Mr. Eberwein.

Crossroads Systems

The fund plans to acquire up to a total of about 1.2 million shares of Crossroads Systems, according to the purchase trading plan, which Lone Star revealed in a previous filing.

Crossroads Systems is engaged in production of various solutions for data archiving. The company has recently filed a lawsuit against Oracle Corporation (NASDAQ:ORCL), blaming it of infriging Crossroads’ patents in some of its storage systems. According to a statement from Crossroads Systems, the company “seeks monetary damages and an injunction.”

 “Crossroads invested millions of dollars in developing and protecting the technology covered by our patents and we are committed to pursuing those remaining companies, like Oracle, who continue to use our patented technology without a license,” the statement quoted Crossroads’ interim President and CEO, Richard K. Coleman as saying.

The stock of the company is down by over 40% since the beginning of the year.

In addition to Lone Star, which just recently joined the family of Crossroads shareholders, some other hedge funds also hold long positions in the company. Millennium Management, led by Israel Englander owns around 436,500 shares according to its latest 13F; Mark N. Diker’s Diker Management reported holding some 316,000 shares of the company.

Disclosure: none

Recommended Reading:

Altai Capital Limits Exposure to Intralinks Holdings

Mario Gabelli, Gamco Slightly Increase Holding in Media General

Davidson Kempner Discloses Significant Position in Levy Acquisition Corp




Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!